George Simeakis | Medicine and Health Sciences | Best Researcher Award

Posted on by Popular Scientist

Dr. George Simeakis | Medicine and Health Sciences | Best Researcher Award

Consultant Endocrinologist 401 General Military Hospital of Athens Greece

Dr. George Simeakis is a dedicated Greek endocrinologist with a remarkable career spanning over a decade. Currently serving as a Consultant Endocrinologist and Training Program Coordinator at the 401 General Military Hospital of Athens, he specializes in thyroid cancer and endocrine neoplasia. His contributions to thyroid cancer management and advanced endocrinology have made him a respected figure in his field.

Profile

Scopus

Orcid

Education 🎓

  • Ph.D. (Athens University School of Medicine, 2014–2024): Focused on the effects of glucocorticoids on bone metabolism in multiple sclerosis patients.
  • Subspecialty training in Thyroid Cancer (Alexandra Hospital, Athens, 2019–2021).
  • Visiting Fellow (Thyroid Oncology, Pisa, Italy, 2021).
  • Residency in Endocrinology (Alexandra Hospital, Athens).
  • Residency in Internal Medicine (401 General Military Hospital, Athens).

Experience đź’Ľ

  • Teacher, National and Kapodistrian University of Athens (Postgraduate Program in Endocrine Neoplasias, 2023–Present).
  • Consultant Endocrinologist, Thyroid Cancer Outpatient Clinic (2021–Present).
  • Training Program Coordinator, 401 General Military Hospital.
  • Private Practice Endocrinologist (Since 2013).
  • Sub-investigator and researcher in groundbreaking projects on thyroid cancer, circulating tumor markers, and more.

Research Interests 🔬

Dr. Simeakis’s research focuses on:

  • Thyroid cancer diagnostics and treatment, including radiofrequency ablation techniques.
  • Circulating tumor DNA (ctDNA) and cells (CTCs) in endocrine malignancies.
  • Bone health in autoimmune disorders like multiple sclerosis.

Awards & Honors 🏆

  • D. Ikkos Award (2024): Best publication in clinical endocrinology.
  • Chairmanship of Basic Cancer Symposium, 46th European Thyroid Association Meeting (2024).
  • Discussion Leader, Medullary Thyroid Cancer Poster Session (2024).

Publications Top Notes: đź“š

“Radiofrequency Ablation for Locoregional Structural Incomplete Response in Differentiated Thyroid Cancer: Initial Experience in Greece”
Biomedicines, 2025. Read here
Cited by: 12 articles.

“Metastatic Medullary Thyroid Carcinoma: Disease Course, Treatment Modalities and Drug Resistance”
Endocrine, 2023. Read here
Cited by: 25 articles.

“High-Dose Intravenous Steroid Treatment in Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study”
Biomedicines, 2023. Read here
Cited by: 15 articles.

“Management of Endocrine Disease: Medullary Thyroid Cancer and Future Perspectives”
European Journal of Endocrinology, 2022. Read here
Cited by: 20 articles.

 

Patricia Lelo | Health Professions | Women Researcher Award

Posted on by Popular Scientist

Dr. Patricia Lelo | Health Professions | Women Researcher Award

Doctor Pediatric Hospital of Kalembelembe Congo, Democratic Republic of the

Dr. Patricia Lelo is a dedicated medical doctor with a master’s in public health and specialized training in infectious diseases, including HIV and tuberculosis. Currently pursuing a Ph.D. in mental health and sickle cell anemia, Dr. Lelo brings years of experience in pediatric care, infectious diseases, and public health research. She is known for her exemplary leadership and contributions to pediatric HIV/AIDS care in the Democratic Republic of Congo (DRC).

Profile

Scopus

Education 🎓

Dr. Lelo has a master’s degree in public health and holds several certifications in infectious diseases management, including specialized training in pediatric HIV and tuberculosis. She is currently advancing her academic career as a Ph.D. candidate, focusing on mental health and sickle cell anemia.

Experience 🏥

Since 2004, Dr. Lelo has served as Executive Deputy Head of the Infectious and Chronic Diseases Department at Kalembelembe Pediatric Hospital in Kinshasa, DRC. Her role includes overseeing care and treatment for children infected with and exposed to HIV/AIDS, managing opportunistic infections, tuberculosis, and sickle cell anemia in children. Additionally, she monitors and evaluates HIV/AIDS care programs and has worked as Assistant Coordinator for the SARA project, an initiative to expand HIV prevention and treatment services across DRC.

Research Interests 🔬

Dr. Lelo’s primary research interests include pediatric HIV, tuberculosis, sickle cell disease, and mental health. She is particularly passionate about improving outcomes for children affected by HIV/AIDS and TB, with a focus on comprehensive care and innovative approaches to disease management.

Awards 🏆

Dr. Lelo’s commitment to pediatric healthcare and infectious disease management has earned her recognition at both national and international levels. She has been a key contributor to training programs and projects that support HIV and TB care in children, underscoring her impactful contributions to global health.

Publications Top Notes:đź“š

Dr. Lelo has co-authored several peer-reviewed articles on topics such as pediatric HIV, prevention of mother-to-child transmission (PMTCT), and the intersection of mental health with infectious diseases. Here are a few notable publications:

Transition to dolutegravir-based ART in 35 low-and middle-income countries: A global survey of HIV care clinics

Lessons Learned from the Impact of HIV Status Disclosure to Children after First-Line Antiretroviral Treatment Failure in Kinshasa, DR Congo

COVID-19 associated changes in HIV service delivery over time in Central Africa: Results from facility surveys during the first and second waves of the pandemic

HIV Disclosure to Infected Children Involving Peers: A New Take on HIV Disclosure in the Democratic Republic of Congo